To better track the spread of COVID-19, the U.S. Food and Drug Administration (FDA) may approve broader use of “pooled testing,” wherein diagnostic tests can be processed in batches rather than one at a time. 

With this strategy, samples from five to 10 individuals could be tested once as a single “pooled” sample, Dr. Brett Giroir, deputy secretary of Health and Human Services, said in a press briefing on June 23, The New York Times reported. The FDA has outlined steps for test developers to design and seek approval for such protocols, according to a statement published June 16.



Source link